Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
32.34
+3.79 (13.27%)
At close: Aug 14, 2026, 4:00 PM EDT
32.51
+0.16 (0.51%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Faeth Therapeutics Market Cap
Faeth Therapeutics has a market cap or net worth of $835.68 million as of August 14, 2026. Its market cap has increased by 8,664.24% in one year.
Market Cap
835.68M
Enterprise Value
649.83M
1-Year Change
8,664.24%
Ranking
Category
Stock Price
$32.34
ChartMarket Cap Chart
Since February 4, 2021, Faeth Therapeutics's market cap has increased from $558.65M to $835.68M, an increase of 49.59%. That is a compound annual growth rate of 7.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 835.68M | 6,109.55% |
| Dec 31, 2025 | 13.46M | 9.18% |
| Dec 31, 2024 | 12.33M | -28.74% |
| Dec 29, 2023 | 17.30M | -62.21% |
| Dec 30, 2022 | 45.77M | -74.21% |
| Dec 31, 2021 | 177.46M | -68.23% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aclaris Therapeutics | 834.62M |
| Climb Bio | 834.55M |
| Obsidian Therapeutics | 825.37M |
| DBV Technologies | 814.55M |
| Silence Therapeutics | 814.03M |
| Aura Biosciences | 789.19M |
| Attovia Therapeutics | 788.08M |
| Oculis Holding AG | 785.66M |